Clinical outcomes of low-dose aspirin administration in patients with variant angina pectoris

Saved in:
Bibliographic Details
Published inInternational journal of cardiology Vol. 167; no. 5; pp. 2333 - 2334
Main Authors Kim, Min Chul, Ahn, Youngkeun, Park, Keun Ho, Sim, Doo Sun, Yoon, Nam Sik, Yoon, Hyun Ju, Kim, Kye Hun, Hong, Young Joon, Park, Hyung Wook, Kim, Ju Han, Jeong, Myung Ho, Cho, Jeong Gwan, Park, Jong Chun, Kang, Jung Chaee
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 01.09.2013
Elsevier
Subjects
Adult
Aged
Angina Pectoris, Variant - drug therapy
Angina Pectoris, Variant - epidemiology
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Aspirin
Aspirin - administration & dosage
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Cardiology. Vascular system
Cardiovascular
Coronary heart disease
Ergonovine
Female
Follow-Up Studies
Heart
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Retrospective Studies
Treatment Outcome
Variant angina pectoris
Aspirin
Variant angina pectoris
Ergonovine
Human
Prostaglandin-endoperoxide synthase
Prognosis
Enzyme
Low dose
Enzyme inhibitor
Patient
Cardiovascular disease
Acetylsalicylic acid
Angina pectoris
Coronary heart disease
Antiplatelet agent
Non steroidal antiinflammatory agent
Analgesic
Antipyretic
Evolution
Oxidoreductases
Salicylates
Cardiology
Variant angina
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2012.11.010